Submit Deal

ACORDA THERAPEUTICS INC

Summary

Acorda Therapeutics is an American biotechnology company developing therapies for people with neurological disorders such as Parkinson's disease or multiple sclerosis.

Deals Overview

Total Deals3

Valued Deals1

Total Value£ 148 M

Avg. Deal Size£ 148 M

Market Context

Subsidiaries

ACORDA THERAPEUTICS INC (MANUFACTURING AND PACKAGING OPERATIONS)

1 transaction

Senior Management

Ron Cohen
CEO and President
Michael Gesser
CFO
Tierney Saccavino
Executive Vice President of Corporate Communications

Sort

19 Jan 2016|Finland|Pharmaceuticals

Target: BIOTIE THERAPIES OYJ

Bidder: ACORDA THERAPEUTICS INC

8 Service Providers

3 Target | 5 Bidder

2 Dealmakers

2 Target

n/a

Value

13 Jan 2021|United States|Containers and Packaging

Target: ACORDA THERAPEUTICS INC (MANUFACTURING AND PACKAGING OPERATIONS)

Bidder: CATALENT INC

4 Service Providers

2 Bidder | 2 Vendor

8 Dealmakers

3 Bidder | 5 Vendor

n/a

Value

01 Apr 2024|United States|Biotechnology

Target: ACORDA THERAPEUTICS INC

Bidder: MERZ THERAPEUTICS

10 Service Providers

6 Target | 4 Bidder

50 Dealmakers

3 Target | 47 Bidder

£ 147 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy